AstraZeneca to cut 400 jobs, mostly in Wilmington
AstraZeneca said Thursday it will cut 400 jobs, with most at the company's Wilmington headquarters.
AstraZeneca to cut 400 jobs, mostly in Wilmington
David Sell
AstraZeneca said Thursday it will cut 400 jobs, with most coming at the company's Wilmington headquarters and "some field-based, non-sales roles," in other parts of the country.
The company said about 70 of the estimated 400 job cuts will come from existing vacancies. As often happens, those who want to leave can raise their hands, perhaps saving others from being let go.
None of these cuts will be at the AstraZeneca manufacturing facility in Newark, Del.
AstraZeneca said all decisions will be finalized by early December.
“This will be very difficult for our entire organization, particularly the people who are directly impacted,” Rich Fante, president, AstraZeneca U.S. & CEO, North America, said in a statement.
“However, these changes are necessary to build a leaner, more efficient organization that will enable the company to continue delivering against our mission of patient health and sustaining a strong business for years to come.”
why don't they just admit they want to pad their earnings so the CEO can make his profit targets?
USAFirst1
shareholders first!! :) pennyrobinson
wah wah wah....why don't you two go down and protest with the rest of the complaining cry babies... BillyDelco
Well, at least it sounds like none of the hot salesgirls are getting fired. Roger Podacter
This "CEO" was paid 4.9 million (salary plus other "compensation", 2010). Good job. Well done. Worth every penny. CiceroSpuriousDeodatus
Too bad CEO's aren't unionized. Apparently that is what's needed to get idiots like BillyDelco to even LOOK at performance. Maybe then the rest of the ideologically stunted would actually see where the REAL theft is taking place in this country. Yeah, this scank was worth his salary. CiceroSpuriousDeodatus- wah wah wah again. Too bad you are most likely an art school dropout saddened by your current lot in life. AZ is a fine company that makes money. The CEO is entitiled to whatever his contract states. Do think Ryan Howard should give money back for that performence last night?
BillyDelco - If AZ was such a "fine company," they wouldn't need to let go 400 people. It's funny how those responsible for making bad decisions are the first to shirk responsibility, yet when a company makes money it was through "leadership from the top." Typical schoolyard answer from a sycophant like BillyDelco, who probably hates polishing his boss' knob as much as the next guy, yet doesn't even have the stones to admit it. That would be "complaining."
The Destroyer - yes they would, smart guy. Think about it. If your numbers are down, changes must be made to keep the company going. Otherwise, the company goes under and Everyone loses their job. Maybe in fairytale world hard decicsions don't have to be made. Do yourself a favor and take a introductory business class next semester instead of some useless liberal arts class...
BillyDelco
AZ is a British Company. I suspect they intend to ultimately close their US Headquarters in Wilmington. BobSG
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog


